Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Forma Therapeutics, Inc.
Scientific Title
A Phase 1/2, Multicenter, Open-label Study of FT-2102 as a Single Agent and in Combination With Azacitidine or Cytarabine in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome With an IDH1 Mutation